This study examines the effectiveness of third-trimester ultrasound in detecting small-for-gestational age (SGA) babies, highlighting concerns about low detection rates and risks associated with false results.
Researchers analyzed data from the DESiGN trial, focusing on stillbirth and neonatal morbidity outcomes among pregnancies classified as either false-negative, true-positive, false-positive, or true-negative for SGA.
Findings revealed that false-negative SGA results significantly increased the risk of stillbirth compared to true-positive diagnoses, while the implications of false-positive results were also evaluated, indicating potential risks in misclassification during antenatal screening.
There is a lack of comprehensive information on the environmental effects of psychotropic medications, leading to the proposal of Environmentally Conscious Psychopharmacotherapy (ECP), which aims to balance patient needs with environmental concerns.
The authors identified actionable steps for reducing the environmental impact of these medications across different sectors, focusing on careful treatment selection, limiting overprescribing, proper medication disposal, and transparent environmental risk reporting.
They emphasize that many of these ECP practices not only benefit the environment but also improve outcomes for patients and clinicians, while highlighting the need for further research on the environmental impacts of psychotropic medications.
- Understanding older adults with advanced cancer often need rehabilitation services due to functional disabilities; yet, there's inconsistency in referrals from oncologists.
- A study analyzed data from older cancer patients to see what factors led to referrals for rehabilitation and how it affected their daily functioning, quality of life, and survival rates.
- Key findings indicated that cognitive impairment and disability status increased the likelihood of referrals, while multiple medications reduced it; however, referrals did not significantly improve function or survival rates among those referred.
More young people are getting cancer, and many of them are living longer after their treatment, but we need better information about how many there are.
As of January 1, 2020, there are about 2.1 million cancer survivors in the United States who were diagnosed between the ages of 15 and 39.
Most of these survivors are over 10 years past their diagnosis, and the common types of cancer for females include breast and thyroid cancer, while males often have testicular cancer.